Simpson Thacher Represents Underwriters in HK$1.56 Billion Hong Kong IPO and Rule 144A/Regulation S Offering of MicroPort MedBot
11.02.21
This is only gets display when printing
Simpson Thacher represented the underwriters in the initial public offering and Rule 144A and Regulation S offering by Shanghai MicroPort MedBot (Group) Co., Ltd. (“MicroPort MedBot”). MicroPort MedBot offered 36,200,000 H shares in its global offering prior to the exercise of the underwriters’ overallotment option. The base offering size was HK$1.56 billion (approximately US$200.49 million). The H shares of MicroPort MedBot are listed on the Hong Kong Stock Exchange. J.P. Morgan and CICC acted as joint sponsors, joint global coordinators, joint bookrunners and joint lead managers.
Founded in 2015, MicroPort MedBot is top-tier surgical robot company dedicated to designing, developing and commercializing surgical robots to assist surgeons in performing complex surgical procedures.
The Simpson Thacher team for the transaction included Christopher Wong, Quan Zhou, Michelle Leung, Emily Yiu and Vincy Huang (Capital Markets).